FDA approves Teva's generic EpiPen after yearslong delay
Teva agrees to pay $126 million to US hospitals over opioids | Reuters
Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients Business
Teva's Richard Francis launches 'pivot to growth' strategy | Fox Business Video
Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record
Corcept Therapeutics plunges amid patent trial with Teva (NASDAQ:CORT) | Seeking Alpha
Teva recalls one lot of IDArubicin Hydrochloride Injection USP
Teva Will Pay Up to $126 Million to U.S. Hospitals Over Opioids - news.law
Teva Pharmaceuticals USA found liable in opioids case - Newsday
Teva stock plummets 18% after rough quarter in US generic drug market
Teva Pharmaceutical revenue by region 2018-2023 | Statista
Teva, Murphy Formalize North America Headquarters Move with Ceremony in Israel - New Jersey Business Magazine
Governor Phil Murphy signed a Proclamation welcoming Teva … | Flickr
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
Is Teva Pharmaceuticals a Brilliant Contrarian Pick? | The Motley Fool
Teva Pharmaceuticals moving HQ from Montgomery County to New Jersey – thereporteronline
Teva Pharmaceuticals on X: "Teva unveils new world class #pharma facility at #Mumbai R&D center: https://t.co/s0LOWejMwH https://t.co/jKjOxoAaGc" / X
Teva Pharmaceutical: Earnings Trends and Recent Developments
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva Pharmaceutical Stock: Stuck In A Cycle Of Hope And Disappointment | Seeking Alpha
Shlomo Yanai, CEO of Israeli drug maker Teva Pharmaceutical Industries Ltd.'s announces the acquisition of German generic drug maker Ratiopharm during a press conference in Cologne, western Germany, on Thursday, March 18,
20 Ratiopharm Purchased By Teva News Conference Photos & High Res Pictures - Getty Images
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Teva Eyes 25 Percent of the $750 Million EpiPen Market by Year's End | BioSpace
Teva Pharmaceutical Statistics, Facts, Revenue, Subsidiaries
